Navigation Links
Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
Date:5/17/2009

due to AEs was in line with historic lipid-lowering trials.

Separately, the company further announced the allowance of a US patent covering DCCR. The patent entitled "Salts of potassium ATP channel openers and uses thereof" contains claims to salts of diazoxide - including DCCR - as well as pharmaceutical formulations of such salts. Additional applications filed in the US and globally will further enhance the patent portfolio of Essentialis.

Commenting on these developments, Essentialis President and CEO, Dr Iain Dukes said, "Essentialis has convincingly demonstrated the therapeutic utility of DCCR as a triglyceride lowering agent with a superior profile to existing approved drugs. The issuance of the patent covering DCCR provides timely coverage for its future commercial development."

Pivotal phase 3 protocols for very high triglycerides and phase 2 protocols for statin combination therapy are currently being finalized with input from experts and the FDA in parallel with partnering discussions.

About DCCR

DCCR, diazoxide choline controlled release, is an ATP-dependent potassium channel agonist with potential utility in several cardiovascular and metabolic diseases. Extensive Phase 1 testing and investigator-sponsored clinical studies have demonstrated the drug's potential to lower triglycerides, non-HDL cholesterol and LDL-cholesterol while raising HDL-cholesterol. In addition, placebo adjusted weight loss exceeding 5% in an 8-week placebo controlled study and 10% in a 6-month study has been demonstrated. Compositions of matter, formulation and method of use patents for DCCR have been filed worldwide. A fixed dose combination product with a statin is under development.

About Very High Triglycerides

Hypertriglyceridemia, a disease where patients have high blood levels of triglycerides, is associated with increased risk of coronary heart disease
'/>"/>

SOURCE Essentialis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia
2. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
3. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint
9. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Pa. , Sept. 1, 2015 ... fully integrated specialty pharmaceutical company focused on discovering, ... that researchers will be  presenting scientific data on ... an abuse-deterrent, extended-release, oral morphine product candidate, and ... development, at PainWeek 2015 to be ...
(Date:9/1/2015)... - The ... egistry data presented at ESC Congress 2015 ... the evolution of manag ing AF in everyday ...   The first-ever two-year outcomes from the Global Anticoagulant Registry ... that all-cause death was the most frequent major event in more than 17,000 ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015 /PRNewswire/ ... cardiovascular image management market, Frost & Sullivan ... 2015 European Frost & Sullivan Award for ... -based PMI has designed innovative and easy-to-use ... deliver precise and reproducible quantitative results for ...
Breaking Medicine Technology:Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5
... organizer UBM Live announced strong booking levels ... buyers and sellers of high value chemistry. 248 exhibitors ... takes place from February 19th to 22nd of 2013 ... fine and specialty chemical companies that have signed up ...
... 15, 2012  Adamas Pharmaceuticals, Inc., a privately held ... End-of-Phase 2 meeting with the FDA to discuss ... conducted for the registration of Arimenda (memantine HCl ... once-daily fixed dose combination of extended release memantine ...
Cached Medicine Technology:Strong Booking Levels For Informex 2013 2Strong Booking Levels For Informex 2013 3Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™ 2Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™ 3
(Date:9/1/2015)... ... September 01, 2015 , ... MediNatura™, ... an educational workshop for physician assistants (PAs) practicing in orthopedics. The workshop, titled ... was held by Dr. Erick Salado, an orthopedic surgeon at South Florida Bone ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... e-Learning Systems, has become a leader in podiatric, surgical and wound ... Superbones Superwounds Conferences place top national speakers at the podium and across the ...
(Date:8/31/2015)... ... , ... The PT Outcomes Registry is an organized system for collecting data ... Registry is being developed by the American Physical Therapy Association (APTA). , Al Amato, ... to contribute FOTO Outcomes measures as one of the primary global outcomes measures to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics proudly announces ... and Influence by Modern Luxury’s The Atlantan Magazine. , This award for ... Kathy King. Her idea and vision to bring to Atlanta a true luxury ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental ... Western University of Health Sciences to learn more about its integrated approach to ... Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, ...
Breaking Medicine News(10 mins):Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4
... ALEXANDRIA, Va., Aug. 8 /PRNewswire-USNewswire/ National Hospice and,Palliative ... of the 2008 Circle of Life Award(R). This ... programs that,demonstrate superior vision, depth, and scope., ... American Hospital,Association,s annual summit in San Diego. This ...
... levels of testosterone may be a key factor in ... could help explain why males in a population are ... Previous research has linked testosterone, the male sex hormone, ... compared to females, experience more bouts of disease, and ...
... Children,s Hospital & Research Center Oakland continues to lead ... a new medical journal focused on children and teenagers. ... Pediatric Rehabilitation Department, is the founder and editor-in-chief of ... Approach . The quarterly journal released its second issue ...
... Eastern Insurance,Holdings, Inc. (Nasdaq: EIHI ... has executed a definitive agreement to acquire ... a transaction valued at,approximately $14.9 million, including ... wholly owned subsidiary is Employers Security Insurance,Company, ...
... of victims get to hospital quickly enough to limit damage, ... people who have strokes don,t act quickly enough to get ... study finds. , "One of the problems is that a ... stroke," said Kathryn M. Rose, a research associate professor of ...
... Aug. 7 Vapotherm, the,global leader in High ... the Food and Drug Administration (FDA) for Precision,Flow(TM), ... gas,blending, flow control and humidification technology into one ... gases., Other Vapotherm products are currently used ...
Cached Medicine News:Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 2Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 3Health News:Testosterone key to disease transmission 2Health News:Children's Hospital Oakland publishes first of its kind pediatric rehabilitation journal 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 3Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 4Health News:Many Miss Out on Stroke Treatment 2Health News:Many Miss Out on Stroke Treatment 3Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2
... All Infectious Disease ELISA ... well format. Also included ... positive and negative controls, ... stop solution. Use an ...
InBios' Trypanosoma cruzi (chagas disease) is an ELISA system for the detection of antibodies to T.cruzi derived TcF antigen in human serum or plasma This test is intended for professional in vitro d...
... chain reaction (PCR) technology, the worlds leading ... component of Roches blood screening assays and ... of selected unique regions of genetic material ... (that is, to detectable levels) in only ...
The OneTouch Flexx Professional Blood Glucose Monitoring System with OneTouchPro Test Strips sets the standard for safety and convenience with unique off-meter sample application and a wide range of ...
Medicine Products: